NCIt synonyms : Autologous Anti-BCMA/CD19 Dual CAR T Cells GC012F; Autologous GC012F CAR-T Cells;
NCIt definition : A preparation of autologous T-lymphocytes engineered to express two separate chimeric
antigen receptors (CARs) targeting the tumor-associated antigens (TAAs) BCMA and CD19
and fused to as of yet not fully elucidated co-stimulatory domains, with potential
immunostimulating and antineoplastic activities. Upon administration, the autologous
bispecific BCMA/CD19-targeted CAR-T cells GC012F specifically and simultaneously target
and bind to tumor cells expressing BCMA and/or CD19. This induces selective toxicity
in tumor cells that express BCMA and/or CD19. BCMA, a tumor-specific antigen and a
receptor for both a proliferation-inducing ligand (APRIL) and B-cell activating factor
(BAFF), is a member of the tumor necrosis factor receptor superfamily (TNFRSF) and
plays a key role in the survival of B-lymphocytes and plasma cells. BCMA is found
on the surfaces of B-cells and is overexpressed on malignant plasma cells. CD19 is
a B-cell-specific cell surface antigen overexpressed in B-cell lineage malignancies.
The processing platform used, FasT CAR-T, shortens the manufacturing time to produce
the CAR-T cells within 24 hours.;